Filing Details
Ovid Therapeutics Inc. (NASDAQ:OVID) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event.
8k filedNASDAQ:OVID
Ovid Therapeutics Inc. (OVID) Reports Material Event to SEC
Filing Details Ovid Therapeutics Inc. (NASDAQ:OVID) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event. Market Context Ovid…
Market Context
Ovid Therapeutics Inc.'s stock currently trades at $2.73 with a market capitalization of $117.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Ovid Therapeutics Inc.'s stock.
All SEC filings for Ovid Therapeutics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View OVID Stock Page
Frequently Asked Questions
Where can I read OVID's SEC filings?
Browse all filings on our OVID SEC filings page.
What types of SEC filings does Ovid Therapeutics Inc. file?
Public companies like Ovid Therapeutics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.